Authors:
de Jong, JC
Heinen, PP
Loeffen, WLA
van Nieuwstadt, AP
Claas, ECJ
Bestebroer, TM
Bijlsma, K
Verweij, C
Osterhaus, ADME
Rimmelzwaan, GF
Fouchier, RAM
Kimman, TG
Citation: Jc. De Jong et al., Antigenic and molecular heterogeneity in recent swine influenza A(H1N1) virus isolates with possible implications for vaccination policy, VACCINE, 19(31), 2001, pp. 4452-4464
Authors:
Gobbers, E
Oosterlaken, TAM
van Bussel, MJAWM
Melsert, R
Kroes, ACM
Claas, ECJ
Citation: E. Gobbers et al., Efficient extraction of virus DNA by NucliSens extractor allows sensitive detection of hepatitis B virus by PCR, J CLIN MICR, 39(12), 2001, pp. 4339-4343
Authors:
Rimmelzwaan, GF
de Jong, JC
Bestebroer, TM
van Loon, AM
Claas, ECJ
Fouchier, RAM
Osterhaus, ADM
Citation: Gf. Rimmelzwaan et al., Antigenic and genetic characterization of swine influenza A (H1N1) virusesisolated from pneumonia patients in the Netherlands, VIROLOGY, 282(2), 2001, pp. 301-306
Citation: Ecj. Claas, Pandemic influenza is a zoonosis, as it requires introduction of avian-like gene segments in the human population, VET MICROB, 74(1-2), 2000, pp. 133-139
Authors:
Smirnov, YA
Lipatov, AS
Gitelman, AK
Claas, ECJ
Osterhaus, ADME
Citation: Ya. Smirnov et al., Prevention and treatment of bronchopneumonia in mice caused by mouse-adapted variant of avian H5N2 influenza A virus using monoclonal antibody against conserved epitope in the HA stem region, ARCH VIROL, 145(8), 2000, pp. 1733-1741
Authors:
Brandenburg, AH
van Beek, R
Moll, HA
Osterhaus, ADME
Claas, ECJ
Citation: Ah. Brandenburg et al., G protein variation in respiratory syncytial virus group A does not correlate with clinical severity, J CLIN MICR, 38(10), 2000, pp. 3849-3852
Authors:
Barnett, JM
Cadman, A
Gor, D
Dempsey, M
Walters, M
Candlin, A
Tisdale, M
Morley, PJ
Owens, IJ
Fenton, RJ
Lewis, AP
Claas, ECJ
Rimmelzwaan, GF
De Groot, R
Osterhaus, ADME
Citation: Jm. Barnett et al., Zanamivir susceptibility monitoring and characterization of influenza virus clinical isolates obtained during phase II clinical efficacy studies, ANTIM AG CH, 44(1), 2000, pp. 78-87
Authors:
Govorkova, EA
Gambaryan, AS
Claas, ECJ
Smirnov, YA
Citation: Ea. Govorkova et al., Amino acid changes in the hemagglutinin and matrix proteins of influenza A(H2) viruses adapted to mice, ACT VIROLOG, 44(5), 2000, pp. 241-248
Authors:
Smirnov, YA
Lipatov, AS
Van Beek, R
Gitelman, AK
Osterhaus, ADME
Claas, ECJ
Citation: Ya. Smirnov et al., Characterization of adaptation of an avian influenza a (H5N2) virus to a mammalian host, ACT VIROLOG, 44(1), 2000, pp. 1-8
Authors:
Rimmelzwaan, GF
Baars, M
van Beek, R
de Lijster, P
de Jong, JC
Claas, ECJ
Osterhaus, ADME
Citation: Gf. Rimmelzwaan et al., Influenza virus subtype cross-reactivities of haemagglutination inhibitingand virus neutralising serum antibodies induced by infection or vaccination with an ISCOM-based vaccine, VACCINE, 17(20-21), 1999, pp. 2512-2516
Authors:
Voeten, JTM
Brands, R
Palache, AM
van Scharrenburg, GJM
Rimmelzwaan, GF
Osterhaus, ADME
Claas, ECJ
Citation: Jtm. Voeten et al., Characterization of high-growth reassortant influenza A viruses generated in MDCK cells cultured in serum-free medium, VACCINE, 17(15-16), 1999, pp. 1942-1950
Authors:
de Jong, JC
van Nieuwstadt, AP
Kimman, TG
Loeffen, WLA
Bestebroer, TM
Bijlsma, K
Osterhaus, ADME
Claas, ECJ
Citation: Jc. De Jong et al., Antigenic drift in swine influenza H3 haemagglutinins with implications for vaccination policy, VACCINE, 17(11-12), 1999, pp. 1321-1328
Authors:
Rimmelzwaan, GF
Claas, ECJ
van Amerongen, G
de Jong, JC
Osterhaus, ADME
Citation: Gf. Rimmelzwaan et al., ISCOM vaccine induced protection against a lethal challenge with a human H5N1 influenza virus, VACCINE, 17(11-12), 1999, pp. 1355-1358
Authors:
Smirnov, YA
Lipatov, AS
Gitelman, AK
Okuno, Y
Van Beek, R
Osterhaus, ADME
Claas, ECJ
Citation: Ya. Smirnov et al., An epitope shared by the hemagglutinins of H1, H2, H5, and H6 subtypes of influenza A virus, ACT VIROLOG, 43(4), 1999, pp. 237-244